Strategic Investment Advisors Gsk PLC Transaction History

Strategic Investment Advisors

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 13, 2021	SELL	$34.07 - $39.94 $186,499 - $218,631	-5,474 Closed	0 $0
Q3 2020 Oct 14, 2020	SELL	$38.11 - $42.99 $198,057 - $223,419	-5,197 Reduced 48.7%	5,474 $206,000
Q2 2020 Aug 04, 2020	SELL	$37.87 - $43.58 $24,956 - $28,719	-659 Reduced 5.82%	10,671 $435,000
Q1 2020 Apr 13, 2020	BUY	$32.47 - $48.83 $5,974 - $8,984	184 Added 1.65%	11,330 $429,000
Q4 2019 Jan 23, 2020	BUY	$42.0 - $48.25 $13,482 - $15,488	321 Added 2.97%	11,146 $524,000

Q3 2019 Oct 25, 2019	BUY	$40.46 - $43.52 $31,680 - $34,076	783 Added 7.8%	10,825 $462,000
Q2 2019 Jul 23, 2019	BUY	$39.4 - $42.7 $39,360 - $42,657	999 Added 11.05%	10,042 $402,000
Q1 2019 Apr 30, 2019	BUY	$38.57 - $42.69 $14,849 - $16,435	385 Added 4.45%	9,043 $378,000
Q4 2018 Feb 08, 2019	BUY	$37.8 - $42.69 $327,272 - $369,610	8,658 New	8,658 $331,000

175K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $79.6B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Strategic Investment Advisors , based on Form 13F filings with the SEC.

Stay updated on Strategic Investment Advisors with notifications on news.